NCT03233594

Brief Summary

Central nervous system (CNS) changes associated with pain have been difficult to measure until the development of functional neuroimaging techniques such as positron emission tomography (PET). We have previously observed asymmetry in the thalamus associated with chronic pain that altered during acupuncture therapy. Imaging studies of therapeutic techniques for chronic pain in animals and humans have been quite limited. This study will be the first to utilize FDG PET-MRI imaging of both the brain and body in order to assess CNS changes and peripheral body changes related to chronic pain and its potential management.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2017

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 7, 2017

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

June 29, 2017

Completed
29 days until next milestone

First Posted

Study publicly available on registry

July 28, 2017

Completed
8.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

July 25, 2025

Status Verified

July 1, 2025

Enrollment Period

8.8 years

First QC Date

June 29, 2017

Last Update Submit

July 24, 2025

Conditions

Keywords

Chronic Pain SyndromeChronic PainChiropracticPETMRIPositron emission tomographyMagnetic resonance imagingNeuro Emotive Technique (NET)

Outcome Measures

Primary Outcomes (1)

  • Use combined PET/MRI to define pain activity pattern and inflammation.

    To use PET-MRI to define abnormal brain and body activity and evaluate changes in inflammation in painful regions in patients with chronic pain syndromes.

    Baseline and 8 weeks

Secondary Outcomes (1)

  • Use combined PET/MRI to demonstrate brain and body activity in responders and non-responders.

    Baseline and 8 weeks

Other Outcomes (4)

  • Brief Pain Inventory Questionnaire

    Baseline and 8 weeks

  • Numeric Rating Scale for Pain Intensity for specific locations

    Baseline and 8 weeks

  • Profile of Mood Scale

    Baseline and 8 weeks

  • +1 more other outcomes

Study Arms (2)

Chiropractic Group

Participants receiving a chiropractic care technique Neuro Emotive Technique (NET) will complete initial pain evaluations and questionnaires for chronic pain symptoms. After approximately 8 weeks participants will receive follow evaluation for pain. Pre and Post PET-MRI scan will be conducted to evaluate changes.

Other: Chiropractic Group

Healthy Control Group

Participants will receive initial evaluations and questionnaires followed by a PET-MRI scan.

Other: Healthy Control Group

Interventions

Participants will receive approximately 8 weeks of chiropractic care.

Chiropractic Group

Participants will not receive any interventions.

Healthy Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects will be recruited only if they are already planning on receiving standard clinical chiropractic care for their pain.

You may qualify if:

  • Age greater than 18 years old.
  • Have chronic pain symptoms for \>3 months;
  • Have moderate pain (\>3/10) in 2 or more areas for more than 5 out of 7 days
  • Is planning on undergoing chiropractic care for the clinical management of the chronic pain.
  • May be on pain medications provided that they are on a stable dose for at least 1 month
  • Patients have no other pre-existing and active significant medical, neurological, or psychological disorders.
  • Minor, stable health problems that should have no substantial effect on cerebral blood flow will be allowed (i.e. controlled hypertension, medication controlled diabetes).
  • Patients will be allowed to be taking medications or supplements at the initial intake, but they must be on a stable dose regimen for at least 1 month.
  • Able to give informed consent and willing to complete the study at Thomas Jefferson University and Marcus Institute of Integrative Health.
  • No significant current active medical conditions.
  • Stable medical conditions as determined by the PI are allowed.
  • No brain or body abnormalities that would affect the acquisition or analysis of the scan.

You may not qualify if:

  • Pregnant or breast feeding
  • Enrollment in active clinical trial/ experimental therapy within the prior 30 days.
  • Subject is unable or unwilling to lie still in the scanner (i.e. due to claustrophobia or weight)
  • Subject has metal in their body or other reason that they cannot undergo magnetic resonance imaging.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Thomas Jefferson University, Marcus Institute of Integrative Health Centers

Philadelphia, Pennsylvania, 19107, United States

Location

Thomas Jefferson University, Marcus Institute of Integrative Health Centers

Villanova, Pennsylvania, 19085, United States

Location

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Andrew B. Newberg, MD

    Thomas Jefferson University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2017

First Posted

July 28, 2017

Study Start

June 7, 2017

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

July 25, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations